相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases
Philip C. Mack et al.
CANCER (2020)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon et al.
SCIENCE (2020)
Integrating genomic features for non-invasive early lung cancer detection
Jacob J. Chabon et al.
NATURE (2020)
Electric Field-Induced Release and Measurement (EFIRM) Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva
Michael Tu et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
Jordi Remon et al.
PLOS ONE (2020)
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer
Natasha B. Leighl et al.
CLINICAL CANCER RESEARCH (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal et al.
JAMA ONCOLOGY (2019)
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy
Pablo Reclusa et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment
Fang Wei et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
A. K. Krug et al.
ANNALS OF ONCOLOGY (2018)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Sujuan Yang et al.
CANCER BIOLOGY & THERAPY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Liquid Biopsy in Lung Cancer A Perspective From Members of the Pulmonary Pathology Society
Lynette M. Sholl et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
Karin Birkenkamp-Demtroder et al.
EUROPEAN UROLOGY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
Ji Yun Lee et al.
ONCOTARGET (2016)
Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study
Dan Pu et al.
THORACIC CANCER (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma
Philip Burnham et al.
SCIENTIFIC REPORTS (2016)
Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma
Florence Mauger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Tony Mok et al.
CLINICAL CANCER RESEARCH (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Landscape of MicroRNA, Piwi-Interacting RNA, and Circular RNA in Human Saliva
Jae Hoon Bahn et al.
CLINICAL CHEMISTRY (2015)
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer et al.
CLINICAL CHEMISTRY (2015)
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
Fang Wei et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Alison S. Devonshire et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Reck et al.
ANNALS OF ONCOLOGY (2014)
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Caitlin Williams et al.
CELL RESEARCH (2014)
Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2014)
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
Sebastien Couraud et al.
CLINICAL CANCER RESEARCH (2014)
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
Francois-Clement Bidard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer
Christoph Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA
John A. Martignetti et al.
NEOPLASIA (2014)
Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM)
Fang Wei et al.
BIOSENSORS & BIOELECTRONICS (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Single-stranded DNA library preparation for the sequencing of ancient or damaged DNA
Marie-Theres Gansauge et al.
NATURE PROTOCOLS (2013)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2012)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
Tony K. F. Yung et al.
CLINICAL CANCER RESEARCH (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: Impact of primary or secondary mutations
Akira Sakurada et al.
CLINICAL LUNG CANCER (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
